PG BUE Week ended 31 Jul 2026

Weekly Investor Report

The Procter & Gamble Company · Consumer Defensive · Household & Personal Products

Open interactive chart View report data
Latest close 15,200 ARS
-3.0% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 1.7% above the Trend Line and sits at 64.5% of its 52-week range. The latest completed week returned -3.0%, after a -5.0% four-week move. The latest news-sentiment score is 45/100.

Setup score 48 out of 100
Latest Close 15,200 ARS 31 Jul 2026
1W Return -3.0% latest completed week
4W Return -5.0% short-term follow-through
12W Return 4.5% quarterly tape
Trend Breadth 57.7% 30 of 52 weeks active
Volume Ratio 1.7x vs 13-week average
What is working
  • The trend backdrop is active with a 3-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -3.0% Latest completed week; four-week move -5.0%. Indicator stack 42/62 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 45/100 32 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 1.7% above the Trend Line and sits at 64.5% of its 52-week range. The latest completed week returned -3.0%, after a -5.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5712-week average 0.38

12-week confirmation

Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.57Current proprietary activity-pressure read.
Buy signals2Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -5.0% over four weeks, 4.5% over 12 weeks, and 10.3% over one year. The current trend has remained active for 3 consecutive weeks.

Performance by holding period

1W-3.0%
4W-5.0%
12W4.5%
26W0.2%
52W10.3%
Active trend streak3 weeks
Active weeks in one year30
Trend breadth57.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.67Latest activity-pressure read.
Pressure change-1.2%Four-week change in activity pressure.
Leadership-17.75Latest relative-leadership reading.
RS change-38.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment45/100

Weighted news tone is neutral across 32 relevant articles.

4 positive · 21 neutral · 7 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-8.4%Distance below the 52-week high.
13-week volatility2.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+4.9%Week of 3 Jul.
Worst week-6.6%Week of 6 Mar.
Latest week-3.0%Week of 31 Jul.

Shape of recent returns

Strong gains3
Modest gains9
Flat weeks0
Modest losses12
Sharp losses2
Recent vol2.8%13-week weekly-return volatility.
Base vol3.3%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew3.0% / -2.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape47/100

Trend, activity pressure, participation, and risk combine to a 47/100 tape read.

 Indicator analysis36/100

Latest 12-week confirmation: trend 3/12, activity pressure 6/12, relative leadership 0/12.

Activity pressure 0.57; No reversal markers Factors50/100

No published factor snapshot is available yet.

 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment45/100

Weighted news tone is neutral across 32 relevant articles.

Orographic Financial Advisors LLC Purchases Shares of 6,979 Procter & Gamble Company (The) $PG Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202615,200 ARS-3.0%14,949 ARS15,913 ARS0.67-17.75121.7KOn
24 Jul 202615,670 ARS0.4%14,931 ARS15,932 ARS0.81-15.4351.9KOn
17 Jul 202615,611 ARS2.5%14,900 ARS15,942 ARS0.81-13.9684.8KOn
10 Jul 202615,233 ARS-4.8%14,876 ARS15,946 ARS0.79-18.5329.7KOff
3 Jul 202615,998 ARS4.9%14,849 ARS15,953 ARS0.68-12.8083.0KOff
26 Jun 202615,253 ARS-0.8%14,799 ARS15,949 ARS0.17-15.3213.8KOff
19 Jun 202615,380 ARS3.1%14,790 ARS15,951 ARS-0.24-19.353.2KOff
12 Jun 202614,920 ARS1.3%14,783 ARS15,951 ARS-0.57-23.5715.0KOff
5 Jun 202614,730 ARS3.5%14,777 ARS15,952 ARS-0.82-18.3932.4KOff
29 May 202614,230 ARS-0.4%14,764 ARS15,952 ARS-0.82-23.52102.2KOff
22 May 202614,290 ARS1.6%14,795 ARS15,954 ARS-0.75-14.98178.1KOff
15 May 202614,060 ARS-3.4%14,850 ARS15,954 ARS-0.60-12.21129.5KOff
8 May 202614,550 ARS-1.3%14,901 ARS15,961 ARS-0.41-11.2587.8KOff
1 May 202614,740 ARS-0.3%14,907 ARS15,961 ARS-0.32-12.26107.7KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.